7Baggers
 Mirum Pharmaceuticals drives liver disease research at NASPGHAN2025  Traders Union Wed, 12 Nov 2025 00:16:07 GMT
 Mirum Pharmaceuticals at Stifel 2025: Optimism in Rare Disease Space  Investing.com Tue, 11 Nov 2025 15:23:50 GMT
 Published on: 2025-11-10 20:09:07  newser.com Tue, 11 Nov 2025 02:09:07 GMT
 responsive playbooks and the mirm inflection  news.stocktradersdaily.com Fri, 07 Nov 2025 15:40:02 GMT
 Mirum to present new data on liver disease therapies at AASLD meeting  Investing.com Fri, 07 Nov 2025 08:00:00 GMT
 mirum pharmaceuticals engages at naspghan 2025 annual meeting  Traders Union Fri, 07 Nov 2025 00:15:09 GMT
 published on: 2025-11-06 04:51:32  newser.com Thu, 06 Nov 2025 10:51:32 GMT
 mirum pharmaceuticals reports robust q3 growth and milestones  TipRanks Thu, 06 Nov 2025 01:52:46 GMT
 Mirum Pharmaceuticals Lifts Guidance After LIVMARLI Sales Surge  Finimize Wed, 05 Nov 2025 17:16:22 GMT
 mirum pharmaceuticals (mirm) projected to post earnings on tuesday  MarketBeat Wed, 05 Nov 2025 15:19:46 GMT
 what analysts are saying about mirum pharmaceuticals stock  Benzinga Wed, 05 Nov 2025 11:45:21 GMT
 mirum pharmaceuticals stock price target raised to $95 by citizens  Investing.com Wed, 05 Nov 2025 10:58:37 GMT
 published on: 2025-11-04 23:58:50  newser.com Wed, 05 Nov 2025 05:58:50 GMT
 Mirum Pharmaceuticals Reports Strong Q3 2025 Growth  TipRanks Wed, 05 Nov 2025 05:46:25 GMT
 Decoding Mirum Pharmaceuticals Inc (MIRM): A Strategic SWOT Insi  GuruFocus Wed, 05 Nov 2025 05:37:59 GMT
 mirum pharmaceuticals reports q3 eps 5c, consensus (16c)  TipRanks Wed, 05 Nov 2025 00:54:58 GMT
 mirum pharmaceuticals earnings beat by $0.20, revenue topped estimates  Investing.com Wed, 05 Nov 2025 00:45:28 GMT
 Mirum Pharmaceuticals Inc (MIRM) Q3 2025 Earnings: EPS of $0.06  GuruFocus Tue, 04 Nov 2025 21:45:35 GMT
 mirum pharmaceuticals lifts guidance after livmarli sales surge  Finimize Tue, 04 Nov 2025 21:35:55 GMT
 mirum pharmaceuticals q3 2025 earnings call transcript  MarketBeat Tue, 04 Nov 2025 17:28:41 GMT
 Mirum Pharmaceuticals earnings beat by $0.20, revenue topped estimates  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 Why Have Mirum Pharmaceuticals Stocks Plummeted?  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 mirum pharmaceuticals lifts guidance after livmarli sales surge  Finimize Mon, 03 Nov 2025 23:37:18 GMT
 mirum pharmaceuticals to participate in upcoming investor conferences  Markets Financial Content Mon, 03 Nov 2025 08:00:00 GMT
 published on: 2025-11-01 02:12:11  newser.com Sat, 01 Nov 2025 07:12:11 GMT
 published on: 2025-10-31 22:13:03  newser.com Sat, 01 Nov 2025 03:13:03 GMT
 published on: 2025-10-31 03:46:47  newser.com Fri, 31 Oct 2025 08:46:47 GMT
 published on: 2025-10-31 01:07:37  newser.com Fri, 31 Oct 2025 06:07:37 GMT
 published on: 2025-10-30 23:29:10  newser.com Fri, 31 Oct 2025 04:29:10 GMT
 published on: 2025-10-29 01:58:20  newser.com Wed, 29 Oct 2025 06:58:20 GMT
 published on: 2025-10-29 01:50:33  newser.com Wed, 29 Oct 2025 06:50:33 GMT
 published on: 2025-10-28 04:35:21  newser.com Tue, 28 Oct 2025 09:35:21 GMT
 published on: 2025-10-28 02:45:58  newser.com Tue, 28 Oct 2025 07:45:58 GMT
 published on: 2025-10-28 00:12:15  newser.com Tue, 28 Oct 2025 05:12:15 GMT

Mirum Pharmaceuticals, Inc
(NASDAQ:MIRM) 

MIRM stock logo

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial ...

Founded: 2018
Full Time Employees: 67
CEO: Christopher Peetz  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends